Sign Out
Patients with asthma should be carefully monitored. Treatment with acetylcysteine should be stopped when bronchospasm occurred. The sulfur odor on opening the sachets does not indicate deterioration of the product, but is due to the active ingredient.
Other drugs should not be used with acetylcysteine solution.
Continue with Google